Key facts
- This page summarizes Yekaterina Chudnovsky's Form 3 filing for Xilio Therapeutics, Inc. (XLO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Sep 2024, 21:00.
Yekaterina Chudnovsky - 07 Jun 2024 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- XLO
- Reported as of
- 07 Jun 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 27 Sep 2024, 21:00:28 UTC
- Prior SEC filing
- 20 Mar 2024
- Next SEC filing
- 21 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Yekaterina Chudnovsky
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Yekaterina Chudnovsky filed Form 3 for Xilio Therapeutics, Inc. (XLO) on 27 Sep 2024.
Change
- Previous filing in this sequence was filed on 20 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,000,000
- Date
- 07 Jun 2024
- Ownership
- Held by GKCC, LLC
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.